About
Small Molecules
Areas of Focus
Categories
Small Molecule PharmaceuticalBoston & New England
Clinical Trials (17)
View allTotal Trials
17
As Lead Sponsor
12
As Collaborator
5
Total Enrollment
4,004
By Phase
PHASE2: 5PHASE4: 2PHASE1: 4PHASE3: 6
By Status
COMPLETED: 13RECRUITING: 2WITHDRAWN: 1TERMINATED: 1
Clinical Trials Pipeline17 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT05753215Collaborator
Controlled Trial of Omadacycline Randomized Treatment Given for Bone and Joint Infection
PHASE2Recruiting
180 participants
Started: May 9, 2023 · Completed: Dec 31, 2025
NCT05515562Collaborator
Effects of Intravenous (IV) Omadacycline on Gut Microbiome
PHASE4Completed
8 participants
Started: Mar 20, 2023 · Completed: Jul 11, 2023
NCT05217537Lead Sponsor
Study to Evaluate the PK of IV and PO Omadacycline in Children and Adolescents With Suspected or Confirmed Bacterial Infections
PHASE1Recruiting
40 participants
Started: Apr 6, 2022 · Completed: Sep 30, 2024
NCT04922554Lead Sponsor
Oral Omadacycline vs. Placebo in Adults With NTM Pulmonary Disease Caused by Mycobacterium Abscessus Complex (MABc)
PHASE2Completed
66 participants
Started: Oct 15, 2021 · Completed: Jul 17, 2024
NCT04460586Collaborator
Pharmacokinetics of Omadacycline in Cystic Fibrosis
PHASE4Completed
9 participants
Started: Jul 1, 2021 · Completed: Dec 31, 2023
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...